Overview
Understanding Krystal Biotech integration
Who this is for: Wholesalers, distributors, pharmacies, hospitals and suppliers that trade with Krystal Biotech, and their purchasing, contract and finance teams.
Scope: This guide describes typical practice for this kind of trading relationship; Krystal Biotech's own program details are confirmed during onboarding.
Krystal Biotech, based in Pittsburgh, develops and markets gene therapies for rare conditions. ECOM's directory lists Krystal Biotech under pharmaceutical manufacturing.
Gene therapies ship under strict cold chain handling to treatment centers and need chain-of-custody data. A pharmaceutical manufacturer typically sells through wholesalers and specialty distributors rather than directly to every pharmacy, so the main documents are orders and shipment notices from the wholesaler side, plus resale (867), inventory and chargeback (844) reporting. Direct accounts, such as hospitals or large chains, add invoices and remittance. DSCSA serialization data travels with product as a supply program requirement. The document set below is typical practice for this type of company; confirm the documents, X12 version, delivery method and testing steps with Krystal Biotech for your own program.
ECOM helps confirm your trading program, map the required documents, configure connectivity, and complete testing against the applicable specifications. It then monitors every file after go-live and handles partner changes, as software, as a managed service or both.